Patent · US Expired

Use for deferiprone

US7049328B2 · kind B2 · utility

12Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2001
Grant dateMay 23, 2006
Priority date—
Expiry dateJun 28, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating iron induced cardiac disease in a patient with iron overload, such as in thalassemia or the like comprising administering to the patient a therapeutically effective amount of deferiprone or a physiologically acceptable salt thereof sufficient to treat iron induced cardiac disease normally associated with iron overload.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.